Jäger W - Search Results

1

In Silico Predictions of Drug - Drug Interactions Caused by CYP1A2, 2C9 and 3A4 Inhibition - a Comparative Study of Virtual Screening Performance.

Kaserer T, Höferl M, Müller K, Elmer S, Ganzera M, Jäger W, Schuster D. Kaserer T, et al. Among authors: jager w. Mol Inform. 2015 Jun;34(6-7):431-57. doi: 10.1002/minf.201400192. Epub 2015 Jun 23. Mol Inform. 2015. PMID: 27490388

2

Tissue pharmacokinetics of ertapenem at steady-state in diabetic patients with leg infections.

Sauermann R, Burian B, Burian A, Jäger W, Höferl M, Stella A, Theurer S, Riedl M, Zeitlinger M. Sauermann R, et al. Among authors: jager w. J Antimicrob Chemother. 2013 Apr;68(4):895-9. doi: 10.1093/jac/dks479. Epub 2012 Dec 4. J Antimicrob Chemother. 2013. PMID: 23212112

3

The effect of the molecular adsorbent recirculating system on moxifloxacin and meropenem plasma levels.

Roth GA, Sipos W, Höferl M, Böhmdorfer M, Schmidt EM, Hetz H, Schebesta K, Klaus D, Motal M, Jäger W, Krenn CG. Roth GA, et al. Among authors: jager w. Acta Anaesthesiol Scand. 2013 Apr;57(4):461-7. doi: 10.1111/aas.12041. Epub 2012 Dec 12. Acta Anaesthesiol Scand. 2013. PMID: 23237505

4

Pharmacokinetics and toxicity of intrathecal liposomal cytarabine in children and adolescents following age-adapted dosing.

Peyrl A, Sauermann R, Chocholous M, Azizi AA, Jäger W, Höferl M, Slavc I. Peyrl A, et al. Among authors: jager w. Clin Pharmacokinet. 2014 Feb;53(2):165-73. doi: 10.1007/s40262-013-0106-1. Clin Pharmacokinet. 2014. PMID: 24129691 Clinical Trial.

5

Interplay of drug metabolizing enzymes with cellular transporters.

Böhmdorfer M, Maier-Salamon A, Riha J, Brenner S, Höferl M, Jäger W. Böhmdorfer M, et al. Among authors: jager w. Wien Med Wochenschr. 2014 Nov;164(21-22):461-71. doi: 10.1007/s10354-014-0301-1. Epub 2014 Sep 10. Wien Med Wochenschr. 2014. PMID: 25271108 Review.

6

Selective anticancer activity of the novel thiobenzanilide 63T against human lung adenocarcinoma cells.

Kucinska M, Piotrowska-Kempisty H, Lisiak N, Kaczmarek M, Dams-Kozlowska H, Granig WH, Höferl M, Jäger W, Zehl M, Murias M, Erker T. Kucinska M, et al. Among authors: jager w. Toxicol In Vitro. 2016 Dec;37:148-161. doi: 10.1016/j.tiv.2016.09.017. Epub 2016 Sep 19. Toxicol In Vitro. 2016. PMID: 27660182

7

Lack of dermal penetration of topically applied gentamicin as pharmacokinetic evidence indicating insufficient efficacy.

Oesterreicher Z, Lackner E, Jäger W, Höferl M, Zeitlinger M. Oesterreicher Z, et al. Among authors: jager w. J Antimicrob Chemother. 2018 Oct 1;73(10):2823-2829. doi: 10.1093/jac/dky274. J Antimicrob Chemother. 2018. PMID: 30113678 Clinical Trial.

8

Identification of Novel Inhibitors of Organic Anion Transporting Polypeptides 1B1 and 1B3 (OATP1B1 and OATP1B3) Using a Consensus Vote of Six Classification Models.

Kotsampasakou E, Brenner S, Jäger W, Ecker GF. Kotsampasakou E, et al. Among authors: jager w. Mol Pharm. 2015 Dec 7;12(12):4395-404. doi: 10.1021/acs.molpharmaceut.5b00583. Epub 2015 Nov 2. Mol Pharm. 2015. PMID: 26469880 Free PMC article.

9

The environmental toxin 2,3,7,8-tetrachlorodibenzo-p-dioxin induces cytochrome P450 activity in high passage PC 3 and DU 145 human prostate cancer cell lines.

Schaufler K, Haslmayer P, Jäger W, Pec M, Thalhammer T. Schaufler K, et al. Among authors: jager w. Int J Mol Med. 2002 Apr;9(4):411-6. Int J Mol Med. 2002. PMID: 11891538

10

Metabolism of dextromethorphan in human liver microsomes: a rapid HPCL assay to monitor cytochrome P450 2D6 activity.

Vielnascher E, Spatzenegger M, Mayrhofer A, Klinger P, Jäger W. Vielnascher E, et al. Among authors: jager w. Pharmazie. 1996 Aug;51(8):586-8. Pharmazie. 1996. PMID: 8794469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters